glp 1 risk of cancer GLP1-RA and thyroid cancers – is there a signal here? – GP Voice Breaking research on GLP-1s and

Takeaway : Review your medications prescribing information before travel

Nature 497(7450):517520

Clinical implication The updated FDA labeling for liraglutide and semaglutide highlights the importance of monitoring depressive symptoms or suicidal thoughts, suggesting treatment discontinuation if such ideations occur [87,88]

losing too fast increases loose skin risk Some patients notice sagging skin after significant weight lossthis can be addressed with surgical or non-surgical procedures if desired Maintaining Your Results GLP-1 medications are a powerful tool, not a replacement for lifestyle changes

They belong to a class of glucagon-like peptide-1 agonists or GLP-1 drugs that work by helping control blood sugar levels and triggering a feeling of fullness

Patient awareness campaigns and digital health platforms are increasing treatment-seeking behavior among urban populations with obesity concerns